Your browser is no longer supported. Please, upgrade your browser.
Settings
ATRC AtriCure, Inc. daily Stock Chart
ATRC [NASD]
AtriCure, Inc.
Index- P/E- EPS (ttm)-1.16 Insider Own3.00% Shs Outstand44.01M Perf Week6.94%
Market Cap1.98B Forward P/E- EPS next Y-0.83 Insider Trans-2.16% Shs Float43.46M Perf Month15.76%
Income-45.70M PEG- EPS next Q-0.28 Inst Own96.60% Short Float4.09% Perf Quarter4.73%
Sales210.10M P/S9.43 EPS this Y-43.20% Inst Trans1.23% Short Ratio4.74 Perf Half Y-8.74%
Book/sh9.49 P/B4.60 EPS next Y17.80% ROA-7.30% Target Price54.38 Perf Year46.21%
Cash/sh5.13 P/C8.50 EPS next 5Y20.00% ROE-14.00% 52W Range23.17 - 51.76 Perf YTD34.20%
Dividend- P/FCF- EPS past 5Y-8.80% ROI-10.40% 52W High-15.71% Beta1.04
Dividend %- Quick Ratio5.90 Sales past 5Y16.50% Gross Margin72.20% 52W Low88.34% ATR1.73
Employees730 Current Ratio6.60 Sales Q/Q-3.20% Oper. Margin-20.00% RSI (14)70.17 Volatility3.90% 4.81%
OptionableYes Debt/Eq0.15 EPS Q/Q54.50% Profit Margin-21.70% Rel Volume0.88 Prev Close43.27
ShortableYes LT Debt/Eq0.15 EarningsNov 05 AMC Payout- Avg Volume374.44K Price43.63
Recom1.40 SMA2012.20% SMA5011.28% SMA2006.76% Volume327,713 Change0.83%
Nov-06-20Reiterated Needham Buy $63 → $53
Apr-07-20Initiated Oppenheimer Outperform $45
Feb-06-20Initiated BTIG Research Buy $42
Jan-24-20Reiterated Needham Buy $39 → $48
Aug-13-19Downgrade Northland Capital Outperform → Market Perform $30
Apr-12-19Initiated JP Morgan Overweight $37
Oct-04-18Reiterated Needham Buy $36 → $39
Aug-02-18Reiterated Stifel Buy $32 → $34
Aug-02-18Reiterated Needham Buy $32 → $36
Jun-18-18Reiterated Needham Buy $26 → $32
Apr-27-18Reiterated Needham Buy $23 → $26
Jan-16-18Reiterated Needham Buy $25 → $23
Nov-02-17Reiterated Needham Buy $26 → $25
Jul-28-17Reiterated Needham Buy $25 → $26
May-30-17Resumed Piper Jaffray Overweight
Jun-30-16Resumed JMP Securities Mkt Outperform
Oct-28-15Reiterated Needham Buy $30 → $23
Oct-06-15Reiterated Needham Buy $32 → $30
Oct-06-15Reiterated Canaccord Genuity Buy $31 → $28
Aug-04-15Reiterated Needham Buy $29 → $32
Nov-19-20 11:44AM  
08:00AM  
Nov-06-20 09:30AM  
Nov-05-20 06:25PM  
04:01PM  
02:30PM  
Oct-29-20 12:35PM  
Oct-26-20 08:00AM  
Oct-13-20 08:00AM  
Oct-06-20 05:41PM  
Sep-28-20 06:39AM  
Sep-01-20 08:00AM  
Aug-06-20 04:00PM  
Aug-03-20 08:55AM  
Jul-30-20 06:39AM  
Jul-29-20 08:00AM  
05:01AM  
Jul-28-20 04:22PM  
04:01PM  
Jul-21-20 12:31PM  
Jul-07-20 08:00AM  
Jun-19-20 12:45PM  
Jun-17-20 04:53AM  
May-11-20 08:10PM  
07:16AM  
May-08-20 08:47AM  
Apr-30-20 11:00AM  
08:30AM  
Apr-29-20 05:25PM  
04:01PM  
Apr-27-20 04:02PM  
Apr-22-20 12:31PM  
Apr-15-20 08:00AM  
Apr-14-20 06:42AM  
Apr-13-20 08:00AM  
Apr-09-20 12:26PM  
08:00AM  
Apr-06-20 04:14PM  
Apr-01-20 03:00PM  
Mar-24-20 05:09PM  
Mar-23-20 02:29PM  
Mar-12-20 09:21AM  
Feb-28-20 02:53PM  
Feb-25-20 10:37PM  
Feb-20-20 05:54AM  
Feb-18-20 04:01PM  
02:30PM  
Feb-03-20 08:00AM  
Jan-31-20 07:33AM  
Jan-28-20 11:15AM  
08:00AM  
Jan-10-20 08:14AM  
Jan-07-20 08:00AM  
Dec-16-19 08:00AM  
Dec-10-19 11:28AM  
Dec-09-19 01:12PM  
Dec-05-19 06:13AM  
Dec-04-19 08:00AM  
Dec-02-19 09:33AM  
Nov-12-19 08:00AM  
Nov-06-19 02:22PM  
Oct-30-19 06:15PM  
04:02PM  
Oct-27-19 02:02PM  
Oct-23-19 10:33AM  
Oct-21-19 08:00AM  
Oct-09-19 06:18PM  
Oct-08-19 11:06AM  
08:00AM  
Sep-02-19 03:18PM  
Aug-28-19 10:50AM  
Aug-27-19 08:00AM  
Aug-26-19 08:00AM  
Aug-14-19 02:26PM  
Aug-13-19 02:16PM  
Aug-12-19 11:04AM  
05:30AM  
Jul-31-19 02:39PM  
08:24AM  
Jul-30-19 06:35PM  
04:02PM  
02:30PM  
Jul-26-19 02:09PM  
Jul-23-19 10:32AM  
Jul-17-19 04:00PM  
Jul-12-19 10:15AM  
Jul-10-19 08:00AM  
Jul-06-19 07:00AM  
Jun-14-19 09:09AM  
May-24-19 01:34PM  
May-05-19 03:53PM  
May-02-19 02:58PM  
May-01-19 07:46PM  
Apr-26-19 07:28AM  
Apr-25-19 05:05PM  
04:01PM  
02:30PM  
Apr-23-19 08:00AM  
Apr-18-19 10:33AM  
Apr-04-19 08:00AM  
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures; EPi-Sense guided coagulation system used for the coagulation of tissue; and COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy. It also provides multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable users to make longer linear lines of ablation. In addition, the company offers cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias; AtriClip system used to occlude the left atrial appendage by mechanically clamping the appendage; and CryoICE CRYO2 cryoablation system to apply cryo-energy to targeted intercostal peripheral nerves in the ribcage and temporarily relieve pain. Further, it provides Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation; Fusion Magnetic Retriever System that allows access around anatomical structures; and cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Drake Scott WilliamDirectorNov 17Buy40.5412,350500,66941,036Nov 19 07:40 AM
Seith Douglas JChief Operating OfficerOct 09Sale40.0929,1611,169,064129,497Oct 13 08:23 AM
Collar Mark ADirectorOct 06Sale40.002,33093,20078,558Oct 08 08:39 AM
Collar Mark ADirectorOct 01Sale40.2067026,93480,888Oct 05 08:45 AM
GROVES REGINA EDirectorSep 14Sale41.836,313264,07321,809Sep 16 04:12 PM
Collar Mark ADirectorJul 01Sale44.604,000178,40081,558Jul 06 08:21 AM
Collar Mark ADirectorMay 12Option Exercise5.1510,00051,50083,106May 14 08:12 AM
CARREL MICHAEL HPresident, CEO, & DirectorMay 12Option Exercise5.9125,000147,750539,147May 13 04:57 PM
CARREL MICHAEL HPresident, CEO, & DirectorMay 12Sale47.0025,0001,175,000514,147May 13 04:57 PM
CARREL MICHAEL HPresident, CEO, & DirectorMay 11Option Exercise5.9125,000147,750539,147May 13 04:57 PM
CARREL MICHAEL HPresident, CEO, & DirectorMay 11Sale46.0025,0001,150,000514,147May 13 04:57 PM
CARREL MICHAEL HPresident, CEO, & DirectorMay 08Option Exercise5.9125,000147,750539,147May 08 05:02 PM
CARREL MICHAEL HPresident, CEO, & DirectorMay 08Sale45.0025,0001,125,000514,147May 08 05:02 PM
Lanning Mark RDirectorApr 27Option Exercise5.1510,00051,500128,434Apr 29 08:03 AM
Noznesky Justin JSVP, Mktg & Business DevelopApr 17Sale40.0010,000400,00051,255Apr 20 08:01 AM
Collar Mark ADirectorApr 07Sale36.074,000144,28073,106Apr 09 08:09 AM
Noznesky Justin JSVP, Mktg & Business DevelopApr 07Sale35.0010,000350,00061,255Apr 09 08:05 AM
Wade M. AndrewCFOFeb 21Option Exercise6.5845,000295,950160,120Feb 24 08:14 AM
Wade M. AndrewCFOFeb 21Sale39.4545,0001,775,400145,120Feb 24 08:14 AM
CARREL MICHAEL HPresident, CEO, & DirectorFeb 14Option Exercise5.9125,000147,750651,490Feb 18 08:07 AM
CARREL MICHAEL HPresident, CEO, & DirectorFeb 14Sale44.0025,0001,100,000626,490Feb 18 08:07 AM
CARREL MICHAEL HPresident, CEO, & DirectorFeb 13Option Exercise5.9125,000147,750651,490Feb 14 08:40 AM
CARREL MICHAEL HPresident, CEO, & DirectorFeb 13Sale43.0025,0001,075,000626,490Feb 14 08:40 AM
CARREL MICHAEL HPresident, CEO, & DirectorFeb 11Option Exercise5.9125,000147,750651,490Feb 12 08:08 AM
Seith Douglas JChief Operating OfficerFeb 11Option Exercise21.0450,0001,052,000201,299Feb 13 08:07 AM
CARREL MICHAEL HPresident, CEO, & DirectorFeb 11Sale42.0025,0001,050,000626,490Feb 12 08:08 AM
CARREL MICHAEL HPresident, CEO, & DirectorFeb 10Option Exercise5.9125,000147,750651,490Feb 12 08:08 AM
CARREL MICHAEL HPresident, CEO, & DirectorFeb 10Sale41.0025,0001,025,000626,490Feb 12 08:08 AM
CARREL MICHAEL HPresident, CEO, & DirectorJan 29Option Exercise5.9125,000147,750651,490Jan 31 07:35 AM
Seith Douglas JChief Operating OfficerJan 29Option Exercise6.7337,000249,010169,682Jan 31 07:32 AM
CARREL MICHAEL HPresident, CEO, & DirectorJan 29Sale40.0025,0001,000,000626,490Jan 31 07:35 AM
Seith Douglas JChief Operating OfficerJan 17Option Exercise6.7338,000255,740147,772Jan 21 08:47 AM
Wade M. AndrewSVP and CFOJan 16Option Exercise6.2710,00062,700155,120Jan 17 07:41 AM
Wade M. AndrewSVP and CFOJan 16Sale36.0010,000360,000145,120Jan 17 07:41 AM
Seith Douglas JChief Operating OfficerJan 16Sale36.0025,471916,956106,272Jan 17 07:44 AM
CARREL MICHAEL HPresident, CEO, & DirectorJan 15Option Exercise5.9125,000147,750651,490Jan 16 07:22 AM
CARREL MICHAEL HPresident, CEO, & DirectorJan 15Sale35.0025,000875,000626,490Jan 16 07:22 AM
Collar Mark ADirectorJan 15Sale35.024,000140,08077,106Jan 17 07:38 AM
CARREL MICHAEL HPresident, CEO, & DirectorJan 14Option Exercise5.9125,000147,750651,490Jan 16 07:22 AM
Wade M. AndrewSVP and CFOJan 14Option Exercise6.2710,00062,700155,120Jan 16 07:55 AM
Wade M. AndrewSVP and CFOJan 14Sale34.0010,000340,000145,120Jan 16 07:55 AM
Seith Douglas JChief Operating OfficerJan 14Sale34.0036,3631,236,342131,743Jan 16 07:31 AM
CARREL MICHAEL HPresident, CEO, & DirectorJan 14Sale34.0025,000850,000626,490Jan 16 07:22 AM
Noznesky Justin JSVP, Mktg & Business DevelopJan 02Option Exercise18.3015,000274,500106,568Jan 06 07:34 AM
CARREL MICHAEL HPresident, CEO, & DirectorJan 02Option Exercise5.9123,546139,157650,036Jan 06 07:36 AM
CARREL MICHAEL HPresident, CEO, & DirectorJan 02Sale33.0023,546777,018626,490Jan 06 07:36 AM
Noznesky Justin JSVP, Mktg & Business DevelopJan 02Sale32.8929,134958,21777,434Jan 06 07:34 AM
Wade M. AndrewSVP and CFODec 26Option Exercise11.201,00011,200145,715Dec 30 07:49 AM
Seith Douglas JChief Operating OfficerDec 26Sale32.0031,4401,006,080168,106Dec 30 07:46 AM
Wade M. AndrewSVP and CFODec 26Sale32.001,00032,000144,715Dec 30 07:49 AM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.